37 citations as recorded by crossref.

1. Antibiotic Therapy for Prosthetic Joint Infections: An Overview B. Le Vavasseur & V. Zeller
2. A commentary on “Dual-route levofloxacin delivery following revision surgery: a synergistic intravenous/intra-articular strategy for enhanced bactericidal effect against prosthetic Pseudomonas aeruginosa infections” W. Ping & Y. Zhao
3. Urine Aluminum Concentration as a Possible Implant Biomarker of Pseudomonas aeruginosa Infection Using a Fluorine- and Phosphorus-Doped Ti-6Al-4V Alloy with Osseointegration Capacity J. Aguilera-Correa et al.
4. Periprosthetic Joint Infection R. Miller et al.
5. Novel Aminoglycoside-Tolerant Phoenix Colony Variants of Pseudomonas aeruginosa D. Sindeldecker et al.
6. High failure rate in Pseudomonas aeruginosa-associated periprosthetic hip and knee joint infections E. Akcicek et al.
7. Outcomes After Pseudomonas Prosthetic Joint Infections B. Kim et al.
8. Application of Phage Therapy in a Case of a Chronic Hip-Prosthetic Joint Infection due toPseudomonas aeruginosa: An Italian Real-Life Experience andIn VitroAnalysis N. Cesta et al.
9. Establishment of a Novel Rat Model of Gram-Negative Periprosthetic Joint Infection Using Cementless Hip Hemiarthroplasty M. Ibrahim et al.
10. Outcomes of the Subsequent Periprosthetic Joint Infection Revisions after a Failed Debridement, Antibiotics and Implant Retention: A Multicentric Study of 197 Patients Á. Auñón et al.
11. High and strikingly early failure-rate following gram-negative periprosthetic joint infection – a retrospective cohort study on 72 cases B. Schlossmacher et al.
12. Antibacterial Activity in Iodine-coated Implants Under Conditions of Iodine Loss: Study in a Rat Model Plus In Vitro Analysis K. Ueoka et al.
13. Exploration of the Pharmacodynamics for Pseudomonas aeruginosa Biofilm Eradication by Tobramycin D. Sindeldecker et al.
14. Piperacillin Steady State Concentrations in Target Tissues Relevant for PJI Treatment—A Randomized Porcine Microdialysis Study Comparing Continuous Infusion with Intermittent Short-Term Infusion H. Rasmussen et al.
15. Multidrug-resistant and extensively drug-resistant Gram-negative prosthetic joint infections: Role of surgery and impact of colistin administration A. Papadopoulos et al.
16. Promising applications of D-amino acids in periprosthetic joint infection M. Caldwell et al.
17. Distinct bacterial population dynamics and disease dissemination after biofilm dispersal and disassembly Y. Ma et al.
18. Above-Knee Amputation in the Setting of a Chronic Soft Tissue Infection and Periprosthetic Joint Infection With Exposed Hardware K. Bennett et al.
19. Lactobacillus cell‐free supernatant as a novel bioagent and biosurfactant against Pseudomonas aeruginosa in the prevention and treatment of orthopedic implant infection A. Jeyanathan et al.
20. Synergistic Activity of Fosfomycin, Ciprofloxacin, and Gentamicin Against Escherichia coli and Pseudomonas aeruginosa Biofilms L. Wang et al.
21. Genomic and transcriptomic profiling of phoenix colonies D. Sindeldecker et al.
22. Pseudomonas aeruginosa prosthetic joint-infection outcomes: Prospective, observational study on 43 patients H. Prié et al.
23. Anti-Pseudomonas aeruginosa Vaccines and Therapies: An Assessment of Clinical Trials M. Elmassry et al.
24. Age-Related Microbiologic Trends in Periprosthetic Joint Infection of the Knee: Increased Rates of Atypical Pathogens With Increasing Age J. Wier et al.
25. Multifunctionality of Nanosized Calcium Apatite Dual-Doped with Li+/Eu3+ Ions Related to Cell Culture Studies and Cytotoxicity Evaluation In Vitro P. Sobierajska et al.
26. Multi-drug delivery system based on lipid membrane mimetic coated nano-hydroxyapatite formulations D. Placente et al.
27. Benefits and Adverse Events Associated With Extended Antibiotic Use in Total Knee Arthroplasty Periprosthetic Joint Infection N. Shah et al.
28. Dual-route levofloxacin delivery following revision surgery: a synergistic intravenous/intra-articular strategy for enhanced bactericidal effect against prosthetic Pseudomonas aeruginosa infections M. Li et al.
29. Pseudomonas aeruginosa Implant-Associated Bone and Joint Infections: Experience in a Regional Reference Center in France M. Cerioli et al.
30. The Use of Antibiotics in Periprosthetic Joint Infection 青. 杨
31. Clinical Outcome of Patients with Acute Periprosthetic Joint Infections Caused by Pseudomonas aeruginosa Compared to Other Gram-Negative Bacilli W. Liu et al.
32. Many Common Pathogens are Present in the Operative Room Air During Surgery E. Chisari et al.
33. Microbiological profiles in periprosthetic joint infections after total knee arthroplasty: a comparative analysis of diabetic and non-diabetic patients M. Ergin et al.
34. A Successfully Treated Patient with Prosthetic Joint Infection Caused by <i>Pseudomonas aeruginosa </i>Diagnosed from PCR of Periprosthetic Joint Fluid K. FURUKAWA et al.
35. Mouse model of Gram-negative prosthetic joint infection reveals therapeutic targets J. Thompson et al.
36. The many antibiotic resistance and tolerance strategies of Pseudomonas aeruginosa D. Sindeldecker & P. Stoodley
37. Predictive Antibiotic Susceptibility Testing by Next-Generation Sequencing for Periprosthetic Joint Infections: Potential and Limitations L. Lüftinger et al.